Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
97.53 -2.00 / -2.01%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
97.53 0.00 / 0.00%
 
Volume: 4.2K

Today’s Trading

Previous close99.54
Today’s open99.02
Day’s range96.64 - 100.18
Volume214,207
Average volume (3 months)345,161
Market cap$3.7B
Dividend yield--
Data as of 4:00pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-27.52%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book7.02

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc-0.02-0.06%
BLUEbluebird bio Inc-3.12-2.52%
KITEKite Pharma Inc-2.30-3.83%
XONIntrexon Corp-0.93-2.01%
Data as of 4:01pm ET, 03/31/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$1.69
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account